This report shows that determination of YB-1 protein expression and its intracellular localisation in tumour cells at the IF are valuable molecular tools to classify grade 2 HNSCC patients into long- and short-term survivors. The gene discussed is YBX1; the disease is head and neck squamous cell carcinoma.